USV Acquires Majority Stake in Wellbeing Nutrition for Rs 1,250 Crore

USV Pvt Ltd has acquired a 79% stake in clean-label nutraceutical brand Wellbeing Nutrition in a deal that values the direct-to-consumer (D2C) startup at Rs 1,583 crore. With this acquisition, USV strengthens its push into the fast-growing consumer wellness segment.

The transaction positions USV to expand aggressively in the premium nutrition and preventive healthcare space, where digital-first purchasing behaviour and proactive health management are driving growth. The move also aligns with the Mumbai-based pharmaceutical company’s broader strategy to enter innovation-led areas such as GLP-1 therapies.

Wellbeing Nutrition has built a strong reputation for its science-backed, clean-label products, including capsules, melts, effervescent tablets, and whole-food-based formulations. The brand has emerged as a premium player with a robust D2C presence.

Over the past two years, Wellbeing Nutrition has delivered 120% growth and expects to surpass Rs 450 crore in revenue by FY27, according to internal projections.

Backed by early investors such as Hindustan Unilever and Fireside Ventures, the startup has differentiated itself through innovative product formats, high-quality natural ingredient sourcing, and a strong omnichannel strategy that includes its own digital platforms.

USV Managing Director Prashant Tewari described the acquisition as a “future-oriented expansion” that reflects evolving consumer preferences toward preventive and proactive wellness. He noted that Wellbeing Nutrition’s clinically backed approach closely aligns with USV’s own quality standards.

Founder Avnish Chhabria said the partnership will allow the brand to scale rapidly without compromising its focus on science and transparency. By leveraging USV’s manufacturing capabilities and global quality systems, the company aims to accelerate growth while preserving its consumer-first culture.

Founded in 1961, USV ranks among India’s leading pharmaceutical companies. It reported FY25 revenue of Rs 5,200 crore and employs more than 7,000 people. The company holds a leading position in oral anti-diabetic and cardiovascular prescriptions in India and markets widely recognised brands such as Glycomet, Ecosprin, Roseday, and Jalra.

USV also serves as the exclusive marketer of the German premium skincare brand Sebamed in India.

Tired of missing hot stocks? Tradz by EquityPandit provides powerful tools like stock scans and more help you make informed trading decisions. Download now and take control of your portfolio!

The post USV Acquires Majority Stake in Wellbeing Nutrition for Rs 1,250 Crore appeared first on Equitypandit.